Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Dymista nasal spray is better and safer than
placebo in treating children ages 4 to <12 years old who have seasonal allergic rhinitis.